Regenerative biologics such as umbilical cordderived Whartons Jelly and MUSE-enriched cell products, along with peptides like BPC-157 and TB-500, are not approved by the U.S
Generally, the effects of slowed gastric emptying are with long-term use of GLP-1 agonists (Joshi, et al., 2023)
However, numerous patients have reported benefit while others have reported no benefit
Wipf, P
Pancreatic Cancer Risk GLP-1RA Drugs: Approved Uses, Benefits, and Common Side Effects The EU Food and Drug Administration has approved several GLP-1RA medications, such as exenatide, liraglutide, albiglutide, dulaglutide, lixisenatide, semaglutide, and tripeptide, offering a range of options for patients seeking treatment
Targeting MYC activity in double-hit lymphoma with MYC and BCL2 and/or BCL6 rearrangements with epigenetic bromodomain inhibitors